pOG44_FLP_recombinase (pEHA1338) Citations (2)

Originally described in: The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability.
Hallacli E, Kayatekin C, Nazeen S, Wang XH, Sheinkopf Z, Sathyakumar S, Sarkar S, Jiang X, Dong X, Di Maio R, Wang W, Keeney MT, Felsky D, Sandoe J, Vahdatshoar A, Udeshi ND, Mani DR, Carr SA, Lindquist S, De Jager PL, Bartel DP, Myers CL, Greenamyre JT, Feany MB, Sunyaev SR, Chung CY, Khurana V Cell. 2022 Jun 9;185(12):2035-2056.e33. doi: 10.1016/j.cell.2022.05.008. PubMed Journal

---

Articles Citing pOG44_FLP_recombinase (pEHA1338)

Articles
Mitochondrial fumarate inhibits Parkin-mediated mitophagy. Ham SJ, Bang S, Woo D, Jo JY, Yoo T, Yoon E, Kyoung Y, Baek D, Kim JS, Chung J. Mol Cell. 2025 Jun 19;85(12):2287-2302.e9. doi: 10.1016/j.molcel.2025.05.021. Epub 2025 Jun 11. PubMed
RNF25 confers mRNA damage tolerance by curbing activation of the integrated stress response. Zhao S, Palma-Chaundler CS, Engel CM, Cordes J, Nixdorf D, Luo MY, Kaya S, Suryo Rahmanto A, van den Heuvel D, Mackens-Kiani T, Weickert P, Lam S, Gupta V, Philippou-Massier J, Bagaric I, Bohlen J, Hewitt G, Luijsterburg MS, Beckmann R, Beli P, Nedialkova DD, Carnie CJ, Subklewe M, Jackson SP, Stingele J. Mol Cell. 2026 Apr 2;86(7):1275-1292.e12. doi: 10.1016/j.molcel.2026.02.024. Epub 2026 Mar 23. PubMed

If you have published an article using this material, please email us at to have your article added to this page.